These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16325690)

  • 1. The metabolic syndrome.
    Jarrett RJ
    Lancet; 2005 Dec; 366(9501):1922; author reply 1923-4. PubMed ID: 16325690
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolic syndrome.
    Balkau B; Eschwège E
    Lancet; 2005 Dec; 366(9501):1921; author reply 1923-4. PubMed ID: 16325688
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China.
    Zhou H; Guo ZR; Yu LG; Hu XS; Xu BH; Liu HB; Wu M; Zhou ZY
    Diabetes Res Clin Pract; 2010 Dec; 90(3):319-25. PubMed ID: 20934770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors, definitions, predictive value & Asian Indian ethnicity: complexities of the metabolic syndrome.
    Misra A; Vikram NK
    Indian J Med Res; 2008 Apr; 127(4):293-6. PubMed ID: 18577782
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the third component of metabolic syndrome really predictive of outcomes in type 2 diabetic patients?
    Monami M; Lambertucci L; Ungar A; Pieri M; Masotti G; Marchionni N; Mannucci E
    Diabetes Care; 2006 Nov; 29(11):2515-7. PubMed ID: 17065696
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolic syndrome and hypogonadism. Testosteron may protect the heart in type 2 diabetes mellitus].
    Schaaf L
    MMW Fortschr Med; 2015 Sep; 157(15):65-7. PubMed ID: 26349733
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preeclampsia - a life-time risk for the mother].
    Schäffer L
    Praxis (Bern 1994); 2012 Apr; 101(8):531-7. PubMed ID: 22492074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of micronucleus frequency with obesity, diabetes and cardiovascular disease.
    Andreassi MG; Barale R; Iozzo P; Picano E
    Mutagenesis; 2011 Jan; 26(1):77-83. PubMed ID: 21164186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.
    Bruno G; Fornengo P; Segre O; Novelli G; Panero F; Perotto M; Zucco C; Bargero G; Cavallo-Perin P
    J Hypertens; 2009 Dec; 27(12):2403-8. PubMed ID: 19738492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
    Saaristo T; Peltonen M; Lindström J; Saarikoski L; Sundvall J; Eriksson JG; Tuomilehto J
    Diab Vasc Dis Res; 2005 May; 2(2):67-72. PubMed ID: 16305061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Programming nutritional and metabolic disorders: the diabetic environment during gestation].
    Motte E; Beauval B; Laurent M; Melki I; Schmit A; Vottier G; Mitanchez D
    Arch Pediatr; 2010 Jan; 17(1):60-70. PubMed ID: 19942417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome.
    Virgin SE; Schmitke JA
    AAOHN J; 2003 Jan; 51(1):28-37. PubMed ID: 12596343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-ankle vascular index is associated with cardiovascular target organ damage and vascular structure and function in patients with diabetes or metabolic syndrome, LOD-DIABETES study: a case series report.
    Gómez-Marcos MÁ; Recio-Rodríguez JI; Patino-Alonso MC; Agudo-Conde C; Gómez-Sánchez L; Gomez-Sanchez M; Rodríguez-Sanchez E; Maderuelo-Fernandez JA; García-Ortiz L;
    Cardiovasc Diabetol; 2015 Jan; 14():7. PubMed ID: 25853841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome.
    Cho LW
    Singapore Med J; 2011 Nov; 52(11):779-85. PubMed ID: 22173246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Diabetes Federation definition of the metabolic syndrome independently predicts future cardiovascular events in Type 2 diabetic patients. The Valpolicella Heart Diabetes Study.
    Targher G; Bertolini L; Tessari R; Zenari L; Arcaro G
    Diabet Med; 2006 Nov; 23(11):1270-1. PubMed ID: 17054609
    [No Abstract]   [Full Text] [Related]  

  • 16. Severity of Metabolic Syndrome as a Predictor of Cardiovascular Disease Between Childhood and Adulthood: The Princeton Lipid Research Cohort Study.
    DeBoer MD; Gurka MJ; Woo JG; Morrison JA
    J Am Coll Cardiol; 2015 Aug; 66(6):755-7. PubMed ID: 26248997
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population.
    Hajat C; Shather Z
    Diabetes Res Clin Pract; 2012 Dec; 98(3):481-6. PubMed ID: 23140808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.
    Guzder RN; Gatling W; Mullee MA; Byrne CD
    Diabetologia; 2006 Jan; 49(1):49-55. PubMed ID: 16341841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter by Bell and O'keefe regarding article, "Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease".
    Bell DS; O'Keefe JH
    Circulation; 2008 Sep; 118(11):e156; author reply e157. PubMed ID: 18779451
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.